Number of patients | 80 | 77 | |
Age (years) | 44 (11) (21–59) | 69 (5) (61–83) | <0.001 |
Male sex | 49 (61%) | 27 (35%) | 0.001 |
FHCM | 22 (28%) | 15 (19%) | 0.237 |
Hypertension | 4 (5%) | 7 (9%) | 0.315 |
NYHA functional class | 2.7 (0.5) | 3.1 (0.4) | <0.001 |
IV | 2 | 10 | |
III | 55 | 62 | |
II | 23 | 5 | |
Syncope | 23 (29%) | 25 (32%) | 0.613 |
Pre-implanted DDD pacemaker | 7 (9%) | 7 (9%) | 0.960 |
IVS thickness (mm) | 23 (4) (16–38) | 22 (3) (15–34) | 0.010 |
Left heart catheterisation | 80 | 77 | |
LVOT gradient |
Rest (mm Hg) | 52 (37) (0–140) | 57 (47) (0–158) | 0.815 |
Post-ES (mm Hg) | 144 (44) (40–236) | 150 (56) (30–250) | 0.413 |
LVEDP (mm Hg) | 20 (6) (8–38) | 19 (6) (8–35) | 0.292 |
LVEF | 0.72 (0.07) (0.60–0.87) | 0.73 (0.07) (0.60–0.90) | 0.318 |
Right heart catheterisation | 75 | 69 | |
Workload (W) | 91 (30) (0–175) | 57 (28) (0–125) | <0.001 |
PAP (mm Hg) | 40 (9) (20–59) | 43 (10) (20–69) | 0.025 |
V̇o2max (ml/kg/min) | 17.4 (4.5) (9.5–28.1) | 12.3 (4.6) (3.9–24.3) | <0.001 |
V̇o2max (% predicted) | 52 (12) (28–82) | 49 (17) (17–92) | 0.363 |
CI (l/m2/min) | 6.4 (1.3) (3.5–9.8) | 5.0 (1.7) (1.6–9.7) | <0.001 |